City

Beijing (1)

Bethesda (1)

Lilongwe (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Recruiting (1)

Unknown status (1)

Phase

phase 2 (3)

Sponsor

AIDS Malignancy Consortium (1)

National Cancer Institute (NCI) (1)

Peking Union Medical College Hospital (1)

UNC Lineberger Comprehensive Cancer Center (1)

Collaborator

Fogarty International Center of the National Institute of Health (1)

National Cancer Institute (NCI) (1)

Intervention

biospecimen collection (1)

etoposide (1)

rituximab (1)

thalidomide, cyclophosphamide and prednisone (1)

tocilizumab (1)

valganciclovir (vgc) (1)

zidovudine (1)

Study Documents

Intervention Type

drug (3)

procedure (1)

Funder Type

Other (3)

NIH (1)

Study Type

Interventional (3)

Observational (1)

multicentric castleman disease

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Collecting Blood and Tissue Sample Donations for Research for

Not yet recruiting

Anal Carcinoma
+11 more

Biospecimen Collection

(no location specified)

Dec 21, 2022

Multicentric Castleman Disease Trial in Lilongwe (Rituximab, Etoposide)

Recruiting

Multicentric Castleman Disease

Lilongwe, Malawi

UNC Project, Kamuzu Central Hospital

May 2, 2022

Castleman Disease, Multicentric Castleman Disease, Giant Lymph Node Hyperplasia Trial run by the NCI (Zidovudine, Tocilizumab,

Completed

Has Results

Castleman Disease
+2 more

Zidovudine
+2 more

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Oct 8, 2020

Multicentric Castleman Disease Trial in Beijing (Thalidomide, cyclophosphamide and prednisone)

Unknown status

Has Results

Multicentric Castleman Disease

Thalidomide, cyclophosphamide and prednisone

Beijing, Beijing, China

Peking Union Medical College Hospital

Apr 5, 2020